Godavari Drugs logo

Godavari Drugs

GODAVARIDRUGSLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹128 Cr
Volatility
Moderate
P/E Ratio
31.7
EBITDA
₹11.10 Cr
Return on Equity
5.39%
Debt to Equity
1.08
Book Value
₹71.05
EPS
₹7.47
52W High
₹135.25
52W Low
₹69.7

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

6
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -2.91% over past five years.
  • Company has a low return on equity of 9.95% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 150 days.
  • Promoter holding has decreased over last 3 years: -12.9%

Growth Rate

Revenue Growth
-6.74% higher than 3Y
Net Income Growth
-6.82% lower than 3Y
Cash Flow Change
-93.48% higher than 3Y
ROE
-46.63% lower than 3Y
ROCE
-47.03% higher than 3Y
EBITDA Margin (Avg.)
-6.87% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
35.42
39.54
43.11
38.64
32.21
26.09
29.55
25.5
23.81
26.65
22.18
33.16
27.96
Expenses
33.17
36.47
39.59
34.17
28.98
23.19
26.97
22.39
20.91
24.65
19.71
30.22
25.44
Operating Profit
2.25
3.07
3.52
4.47
3.23
2.9
2.58
3.11
2.9
2
2.47
2.94
2.52
OPM %
6.35%
7.76%
8.17%
11.57%
10.03%
11.12%
8.73%
12.2%
12.18%
7.5%
11.14%
8.87%
9.01%
Other Income
0.45
0
-0.01
0.08
0.77
0.01
0.1
0.11
0.01
0.64
0.27
0.25
0.15
Interest
1.11
1.3
1.27
1.23
1.44
1.08
1.11
1.11
1
0.91
1.11
0.96
0.9
Depreciation
0.47
0.49
0.5
0.53
0.55
0.58
0.64
0.67
0.6
0.6
0.61
0.61
0.59
PBT
1.12
1.28
1.74
2.79
2.01
1.25
0.93
1.44
1.31
1.13
1.02
1.62
1.18
Tax %
27.68%
32.81%
29.89%
4.66%
18.91%
12.8%
16.13%
38.19%
19.85%
10.62%
25.49%
20.37%
5.93%
Net Profit
0.81
0.86
1.22
2.66
1.63
1.09
0.77
0.89
1.04
1
0.76
1.29
1.11
EPS in Rs
1.08
1.14
1.62
3.53
2.16
1.45
1.02
1.18
1.38
1.33
1.01
1.27
1.1
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
55
71
76
64
84
96
123
161
160
157
113
106
110
Expenses
49
67
70
60
78
90
113
150
150
143
102
95
100
Operating Profit
6
4
5
4
5
6
10
11
10
13
12
10
10
OPM %
11%
6%
7%
6%
7%
6%
8%
7%
6%
8%
10%
10%
9%
Other Income
0
0
1
1
0
0
0
0
1
1
1
1
1
Interest
1
2
3
2
3
3
3
3
4
5
5
4
4
Depreciation
1
1
1
1
1
1
1
2
2
2
2
2
2
PBT
5
2
3
1
2
2
6
7
5
7
6
5
5
Tax %
23%
38%
33%
37%
31%
13%
28%
25%
23%
20%
22%
19%
—
Net Profit
4
1
2
1
1
2
4
5
4
6
4
4
4
EPS in Rs
4.85
1.79
2.4
1.1
1.61
2.66
5.48
6.97
5.03
7.37
5.82
4.04
4.71
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
8
8
8
8
8
8
8
8
8
8
10
Reserves
6
7
9
10
11
13
17
22
26
31
36
66
Borrowings
8
16
16
19
22
28
30
23
36
58
64
82
Other Liabilities
13
21
24
27
33
36
36
49
52
38
35
43
Total Liabilities
35
51
56
63
74
84
91
101
121
135
143
200
Fixed Assets
7
9
13
15
15
14
22
26
25
27
33
30
CWIP
0
1
0
1
2
9
1
0
9
18
30
57
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
27
41
43
47
57
61
68
75
87
90
81
114
Total Assets
35
51
56
63
74
84
91
101
121
135
143
200
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-6
-5
5
4
4
6
1
11
13
18
11
1
Investing
0
-2
-3
-3
-2
-7
-1
-5
-9
-13
-20
-26
Financing
6
7
-2
0
-1
0
0
-6
-4
-6
8
37
Net Cash Flow
0
0
0
1
0
0
0
1
1
0
0
12
Free Cash Flow
-6
-7
1
0
1
-1
0
6
4
5
-9
-26
CFO/OP
-101
-101
108
109
73
108
26
110
143
146
105
19
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
87
126
117
152
148
137
134
126
132
138
136
150
Inventory Days
84
67
70
100
93
84
55
28
57
62
125
217
Days Payable
79
108
124
171
171
144
112
121
132
96
128
163
Cash Conversion Cycle
92
85
63
81
70
78
78
33
58
105
133
204
Working Capital Days
63
44
40
47
38
31
46
32
23
9
11
42
ROCE %
32%
16%
17%
11%
12%
12%
18%
18%
14%
14%
10%
7%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Godavari Drugs insights

61 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

DIIs2.74%Public42.76%Others14.28%Promot.40.23%As ofJun 2026
0.21% of promoter holding pledged as of 10 Sep 2026

Documents

Frequently Asked Questions about Godavari Drugs

What does Godavari Drugs Ltd do?
Incorporated in 1987, Godavari Drugs Ltd manufactures and sale of Active Pharmaceutical Ingredients and their intermediates[1]
Where is Godavari Drugs Ltd (530317) listed?
Godavari Drugs Ltd trades as GODAVARIDRUGSLTD on the NSE and under code GODAVARI on the BSE.
Which sector does Godavari Drugs Ltd belong to?
Godavari Drugs Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Godavari Drugs Ltd?
Godavari Drugs Ltd has a market capitalisation of ₹128.32 Cr, which places it in the Small Cap band.
What is the PE ratio of Godavari Drugs Ltd?
Godavari Drugs Ltd trades at a PE ratio of 31.70, on earnings per share of ₹7.47, against a book value of ₹71.05 per share.
What is the 52-week high and low of Godavari Drugs Ltd?
Over the last 52 weeks Godavari Drugs Ltd has traded between ₹69.7 and ₹135.25.
What is the Return on Equity (ROE) of Godavari Drugs Ltd?
Godavari Drugs Ltd reported a return on equity of 5.39%. Its debt-to-equity ratio is 1.08.

Company Information

Incorporated in 1987, Godavari Drugs Ltd manufactures and sale of Active Pharmaceutical Ingredients and their intermediates[1]

Website godavaridrugs.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530317.md for Godavari Drugs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List